ArticleFrontiers in veterinary science2025
Phylogenetic analysis of a 2024 Sheeppox virus isolate from the Almaty region of Kazakhstan and investigation of its pathogenicity in merino sheep.
Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- An Evaluation of the Efficacy of Four Currently Used Sheep Pox Vaccines Against a Contemporary Virulent Strain.Vaccines · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Sheeppox virus (SPPV) is a significant pathogen that affects small ruminants and causes substantial economic losses. It is essential to perform detailed molecular and pathogenic characterization of field isolates to control the disease and develop prevention strategies. Methods: The SPPV isolate "Sheeppox/KZ/Targap/2024" was obtained in 2024 from a diseased lamb during an outbreak in Targap village in the Almaty region of Kazakhstan. The isolate was passaged three times in lamb kidney-cell culture, and the 50% tissue culture infectious dose (TCID Results: The virus activity was 4.75 ± 0.02 log Conclusion: The findings confirm previously known characteristics of SPPV and provide new insights into the molecular and pathogenic properties of the "Sheeppox/KZ/Targap/2024" isolate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.